文献速递肺结节与肺癌

超声内镜引导下淋巴结穿刺与纵隔镜检查的安全性和费用比较

Safety and Costs of Endobronchial Ultrasound-Guided Nodal Aspiration and Mediastinoscopy.
PubMed 文献 · Chest · 2019-10-09

该回顾性队列研究基于美国MarketScan保险数据库(2007-2015年),比较了30,570例接受EBUS或纵隔镜检查患者的风险与费用。结果显示,严重不良事件在两种操作间无显著差异(0.3% vs 0.4%),但EBUS的声带麻痹发生率更低(1.4% vs 2.2%),且校正后严重不良事件风险(OR 0.42)和声带麻痹风险(OR 0.57)均更低,平均费用也更低。

要点

  • EBUS与纵隔镜的严重不良事件发生率均低且无显著差异。
  • EBUS的声带麻痹发生率显著低于纵隔镜(1.4% vs 2.2%)。
  • EBUS的平均费用比纵隔镜低$2,211,校正后低$1,650。

核心结论

  • 作为孤立操作时,EBUS相比纵隔镜与更低的风险和费用相关。

研究设计与样本

  • 回顾性研究,使用2007-2015年MarketScan美国雇主保险索赔数据库。
  • 共纳入30,570例患者,其中49%接受EBUS。
  • 排除接受多模式纵隔评估(n=1,396)或同日肺切除术(n=2,130)的患者。

主要发现

  • 校正后EBUS与严重不良事件风险降低相关(OR 0.42;95%CI 0.32-0.55)。
  • 校正后EBUS与声带麻痹风险降低相关(OR 0.57;95%CI 0.54-0.60)。

临床怎么用

  • 在需孤立性纵隔淋巴结评估时,可优先考虑EBUS,因其风险更低且费用更少。

局限性

  • 研究基于索赔数据库,可能存在编码偏倚和混杂因素。
  • 结论仅适用于孤立操作,不适用于多模式评估或同日肺切除术患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There remains debate over the best invasive diagnostic modality for mediastinal nodal evaluation. Prior studies have limited generalizability and insufficient power to detect differences in rare adverse events. We compared the risks and costs of endobronchial ultrasound (EBUS)-guided nodal aspiration and mediastinoscopy performed for any indication in a large national cohort. METHODS: We conducted a retrospective study (2007-2015) with MarketScan, a claims database of individuals with employer-provided insurance in the United States. Patients who underwent multimodality mediastinal evaluation (n = 1,396) or same-day pulmonary resection (n = 2,130) were excluded. Regression models were used to evaluate associations between diagnostic modalities and risks and costs while adjusting for patient characteristics, year, concomitant bronchoscopic procedures, and lung cancer diagnosis. RESULTS: Among 30,570 patients, 49% underwent EBUS. Severe adverse events-pneumothorax, hemothorax, airway/vascular injuries, or death-were rare and invariant between EBUS and mediastinoscopy (0.3% vs 0.4%; P = .189). The rate of vocal cord paralysis was lower for EBUS (1.4% vs 2.2%; P < .001). EBUS was associated with a lower adjusted risk of severe adverse events (OR, 0.42; 95% CI, 0.32-0.55) and vocal cord paralysis (OR, 0.57; 95% CI, 0.54-0.60). The mean cost of EBUS was $2,211 less than mediastinoscopy ($6,816 vs $9,023; P < .001). After adjustment this difference decreased to $1,650 (95% CI, $1,525-$1,776). CONCLUSIONS: When performed as isolated procedures, EBUS is associated with lower risks and costs compared with mediastinoscopy. Future studies comparing the effectiveness of EBUS vs mediastinoscopy in the community at large will help determine which procedure is superior or if trade-offs exist.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Verdial FC, Berfield KS, Wood DE, et al. Safety and Costs of Endobronchial Ultrasound-Guided Nodal Aspiration and Mediastinoscopy. Chest. 2019. PMID: 31605700. doi:10.1016/j.chest.2019.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。